Report
Team Research
EUR 120.00 For Business Accounts Only

MOSL: Morning India (9/July/21): 1. India Strategy | Preview 1QFY22 (Vaccinated to grow!); 2. TCS (1QFY22 Result); 3. India Life Insurance

 MOrning India (9/July/21): 1. India Strategy | Preview 1QFY22 (Vaccinated to grow!); 2. TCS (1QFY22 Result); 3. India Life Insurance

 

Today’s top research theme

India Strategy: Vaccinated to grow!

  • FY22 commenced with an odd sense of déjà vu as the second COVID-19 wave swept across the country over Apr-May'21, resulting in localized lockdowns and restrictions The pace of vaccinations has also picked up - India administered 4m vaccines daily, on average, in Jun'21, double the average of 2m vaccines daily in May'21; this is expected to improve further on increased availability. The equity markets have largely looked through the turbulent period of April/May'21 and have shown strong resilience, with indices trading near alltime highs.
  • We expect PBT/PAT to grow 110%/114% for the MOFSL Universe in 1QFY22. Sequentially, though, earnings should moderate 19% each for both the MOFSL Universe and the Nifty. The MOFSL Universe is expected to post a PBT/PAT CAGR of 12%/15% over 1QFY20-1QFY22. On a two-year basis, Metals, Technology, and Private Banks are likely to contribute 104% to incremental 1QFY22 PAT v/s 1QFY20
  • Nifty sales/EBITDA/PBT/PAT should grow 48%/38%/89%/94% YoY in 1QFY22E. Over 1QFY20-1QFY22, the Nifty should post a sales/EBITDA/PBT/PAT CAGR of 2%/11%/12%/16%.
  • Marginal downward revision in Nifty FY22 EPS: Nifty FY22E EPS estimates have seen a downgrade of 2% to INR733 (prior: INR748), while FY23 EPS is stable at INR868 (prior: INR870). As the economy reopens and vaccinations gain momentum, demand recovery could strengthen. We expect earnings to accelerate and estimate an FY21- 23 CAGR of 26% for Nifty EPS.

Piping hot news

Cabinet clears ₹23,123 crore emergency response package to fight Covid

To tackle the Covid-19 pandemic, the Union Cabinet has approved a new emergency response package worth ₹23,123 crore, following the first meeting of Prime Minister Narendra Modi's revamped cabinet on Thursday. Addressing a press briefing, India's new health minister Mansukh Mandaviya said, "To avert the devastation caused by the second Covid wave, the government had announced a ₹23,000-crore relief package."

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Team Research

Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch